Pharmacokinetic characteristics and therapeutic effects of mitomycin C-dextran conjugates after intratumoural injection

This publication has 21 references indexed in Scilit:

• Pharmacokinetic Rationale for Chemotherapeutic Drugs Combined with Intra-Arterial Degradable Starch Microspheres (Spherex®)
  Clinical Pharmacokinetics, 1996
• Antibody-Enzyme Conjugates for Cancer Therapy
  JNCI Journal of the National Cancer Institute, 1996
• Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugs
  Critical Reviews in Oncology/Hematology, 1995
• Polymer Conjugates
  Clinical Pharmacokinetics, 1994
• Barriers to Drug Delivery in Solid Tumors
  Scientific American, 1994
• Tumor Localization and in vivo Antitumor Activity of the Immunoconjugate Composed of Anti‐human Colon Cancer Monoclonal Antibody and Mitomycin C‐Dextran Conjugate
  Japanese Journal of Cancer Research, 1991
• Physicochemical properties and antitumor activities of polymeric prodrugs of mitomycin C with different regeneration rates
  Journal of Controlled Release, 1989
• Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. II. Disposition and pharmacokinetics following intravenous and intramuscular administration
  International Journal of Pharmaceutics, 1987
• Development of a novel polymeric prodrug of mitomycin C, mitomycin C-dextran conjugate with anionic charge. I. Physicochemical characteristics and in vivo and in vitro antitumor activities
  International Journal of Pharmaceutics, 1987
• A pharmacokinetic analysis program (multi) for microcomputer.
  Journal of Pharmacobio-Dynamics, 1981